First Page | Document Content | |
---|---|---|
Date: 2004-03-24 17:54:28Medicine Drug safety Pharmaceutical industry Medical research New Drug Application Pharmacogenomics Investigational New Drug Drug development Biologic License Application Food and Drug Administration Pharmaceutical sciences Pharmacology | Update Issue 2, 2004.inddAdd to Reading ListSource URL: www.lw.comDownload Document from Source WebsiteFile Size: 1,49 MBShare Document on Facebook |
Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmaceDocID: 1uvYN - View Document | |
Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic,DocID: 1sDEk - View Document | |
Emergency Use: means the use of a test article on a human subject in a life-threatening situation inDocID: 1riMu - View Document | |
Microsoft Word - 7494fnl.docDocID: 1qYy2 - View Document | |
Microsoft WorddocDocID: 1qVAJ - View Document |